Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series
- DOI
- 10.1016/s0140-6736(25)00513-6
- Published
- 2025-06
- Container
- The Lancet
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/s0140-6736-25-00513-6,
title = {Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series},
author = {Neil A Shneider and Matthew B Harms and Vlad A Korben and Olivia M Rifai and Benjamin N Hoover and Elizabeth A Harrington and Sonya Aziz-Zaman and Jessica Singleton and Arish Jamil and Vikram R Madan and Julia Yasek and Ikjae Lee and Jinsy A Andrews and Richard M Smiley and Mahabub M Alam and Lauren E Black and Minwook Shin and Jonathan K Watts and David Walk and Daniel Newman and Robert M Pascuzzi and Markus Weber and Christoph Neuwirth and Sandrine Da Cruz and Armand Soriano and Roger Lane and Scott Henry and Joel Mathews and Paymaan Jafar-Nejad and Dan Norris and Frank Rigo and Robert H Brown and Stephan Miller and Rebecca Crean and C Frank Bennett},
year = {2025},
journal = {The Lancet},
doi = {10.1016/s0140-6736(25)00513-6},
url = {https://doi.org/10.1016/s0140-6736(25)00513-6}
}RIS
TY - JOUR TI - Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series AU - Neil A Shneider AU - Matthew B Harms AU - Vlad A Korben AU - Olivia M Rifai AU - Benjamin N Hoover AU - Elizabeth A Harrington AU - Sonya Aziz-Zaman AU - Jessica Singleton AU - Arish Jamil AU - Vikram R Madan AU - Julia Yasek AU - Ikjae Lee AU - Jinsy A Andrews AU - Richard M Smiley AU - Mahabub M Alam AU - Lauren E Black AU - Minwook Shin AU - Jonathan K Watts AU - David Walk AU - Daniel Newman AU - Robert M Pascuzzi AU - Markus Weber AU - Christoph Neuwirth AU - Sandrine Da Cruz AU - Armand Soriano AU - Roger Lane AU - Scott Henry AU - Joel Mathews AU - Paymaan Jafar-Nejad AU - Dan Norris AU - Frank Rigo AU - Robert H Brown AU - Stephan Miller AU - Rebecca Crean AU - C Frank Bennett PY - 2025 JO - The Lancet DO - 10.1016/s0140-6736(25)00513-6 UR - https://doi.org/10.1016/s0140-6736(25)00513-6 ER -
APA
Shneider, N. A., Harms, M. B., Korben, V. A., Rifai, O. M., Hoover, B. N., Harrington, E. A., Aziz-Zaman, S., Singleton, J., Jamil, A., Madan, V. R., Yasek, J., Lee, I., Andrews, J. A., Smiley, R. M., Alam, M. M., Black, L. E., Shin, M., Watts, J. K., Walk, D., Newman, D., Pascuzzi, R. M., Weber, M., Neuwirth, C., Cruz, S. D., Soriano, A., Lane, R., Henry, S., Mathews, J., Jafar-Nejad, P., Norris, D., Rigo, F., Brown, R. H., Miller, S., Crean, R., & Bennett, C. F. (2025). Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series. The Lancet. https://doi.org/10.1016/s0140-6736(25)00513-6
Source records
- crossref · retrieved 2026-09-26T01:22:08.304Z